Keyphrases
Sirolimus
100%
Post-transplant Period
100%
Immunosuppressive Agents
50%
Mammalian Target of Rapamycin (mTOR)
16%
Corticosteroids
16%
Antiproliferative Activity
16%
Highly Effective
16%
Acute Renal Allograft Rejection
16%
Associated Complications
16%
Dynamic Interaction
16%
Renal Transplantation
16%
Early Recognition
16%
Calcineurin Inhibitors
16%
Adverse Effect Profile
16%
Long-term Renal Function
16%
Antimetabolites
16%
Post-transplant Malignancy
16%
Optimal Dosing Strategy
16%
Pharmacokinetic Interaction
16%
Biochemistry, Genetics and Molecular Biology
Pharmacokinetic
100%
Kidney Function
100%
Mechanistic Target of Rapamycin
100%
Calcineurin
100%
Antimetabolite
100%
Medicine and Dentistry
Rapamycin
100%
Immunosuppressive Drug
50%
Cancer
16%
Adverse Event
16%
Atherosclerosis
16%
Kidney Transplantation
16%
Kidney Function
16%
Calcineurin Inhibitor
16%
Mechanistic Target of Rapamycin
16%
Pharmacokinetic
16%
Kidney Allograft Rejection
16%
Antimetabolite
16%
Pharmacology, Toxicology and Pharmaceutical Science
Rapamycin
100%
Immunosuppressive Agent
50%
Pharmacokinetic
16%
Adverse Event
16%
Atherosclerosis
16%
Mammalian Target of Rapamycin
16%
Kidney Allograft Rejection
16%
Antimetabolite
16%
Calcineurin Inhibitor
16%